APA (7th ed.) Citation

Yoshiyama, T., Nakamura, Y., Igawa, A., Saruwatari, A., Shigechi, T., Ueda, N., . . . Ohno, S. (2012). Serum anti-p53 antibody titers predict pathological response to preoperative chemotherapy in women with HER2 positive or triple negative breast cancer. Cancer Research, 72(24a), 921. https://doi.org/10.1158/0008-5472.SABCS12-P3-06-26

Chicago Style (17th ed.) Citation

Yoshiyama, T., et al. "Serum Anti-p53 Antibody Titers Predict Pathological Response to Preoperative Chemotherapy in Women with HER2 Positive or Triple Negative Breast Cancer." Cancer Research 72, no. 24a (2012): 921. https://doi.org/10.1158/0008-5472.SABCS12-P3-06-26.

MLA (9th ed.) Citation

Yoshiyama, T., et al. "Serum Anti-p53 Antibody Titers Predict Pathological Response to Preoperative Chemotherapy in Women with HER2 Positive or Triple Negative Breast Cancer." Cancer Research, vol. 72, no. 24a, 2012, p. 921, https://doi.org/10.1158/0008-5472.SABCS12-P3-06-26.